Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


18.12.2017

1 Acta Neuropathol Commun
1 Acta Oncol
1 Actas Urol Esp
1 Arab J Urol
1 Arch Ital Urol Androl
1 Arch Pathol Lab Med
1 Biophys Rev
1 BJU Int
2 Cancer Biomark
1 Cancer Gene Ther
1 Cancer Invest
1 Cancer Sci
1 Cell Death Dis
1 Clin Cancer Res
1 Clin Rehabil
2 Eur Urol
1 Expert Opin Emerg Drugs
1 Expert Rev Clin Pharmacol
1 Front Physiol
1 Int Braz J Urol
3 Int J Cancer
1 J Cancer Res Ther
1 J Cell Biochem
1 J Clin Oncol
1 J Exp Clin Cancer Res
1 J Geriatr Oncol
1 J Magn Reson Imaging
1 Klin Onkol
1 Minerva Urol Nefrol
3 Oncotarget
2 PLoS One
1 Psychooncology
1 Therapie
3 Urol Clin North Am
1 Urol Nurs
1 Urol Oncol
1 Urologiia
1 Virchows Arch


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol Commun

  1. POPKIROV S, Ayzenberg I, Hahn S, Bauer J, et al
    Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis.
    Acta Neuropathol Commun. 2017;5:40.
    PubMed     Text format     Abstract available


    Acta Oncol

  2. HAQUE W, Lewis GD, Verma V, Darcourt JG, et al
    The role of adjuvant chemotherapy in locally advanced bladder cancer.
    Acta Oncol. 2017 Dec 11:1-7. doi: 10.1080/0284186X.2017.1415461.
    PubMed     Text format     Abstract available


    Actas Urol Esp

  3. BLANCA PEDREGOSA AM, Sanchez-Gonzalez A, Carrasco Valiente J, Ruiz Garcia JM, et al
    Expression of proteins FGFR3, PI3K, AKT, p21Waf1/Cip1 and cyclins D1 and D3 in patients with T1 bladder tumours: clinical implications and prognostic significance.
    Actas Urol Esp. 2017;41:172-180.
    PubMed     Text format     Abstract available


    Arab J Urol

  4. ABOTALEB AA, Kandeel WS, Elmohamady B, Noureldin YA, et al
    Bipolar plasma kinetic enucleation of non-muscle-invasive bladder cancer: Initial experience with a novel technique.
    Arab J Urol. 2017;15:355-359.
    PubMed     Text format     Abstract available


    Arch Ital Urol Androl

  5. DI FRANCO CA, Porru D, Giliberto G, Viglio A, et al
    Vaginal metastasis of bladder urothelial carcinoma: Description of a case and revision of literature.
    Arch Ital Urol Androl. 2017;89:156-157.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  6. KHANI F, Robinson BD
    Precursor Lesions of Urologic Malignancies.
    Arch Pathol Lab Med. 2017;141:1615-1632.
    PubMed     Text format     Abstract available


    Biophys Rev

  7. TAHERI M, Omrani MD, Ghafouri-Fard S
    Long non-coding RNA expression in bladder cancer.
    Biophys Rev. 2017 Dec 8. pii: 10.1007/s12551-017-0379.
    PubMed     Text format     Abstract available


    BJU Int

  8. LIEDBERG F, Gudjonsson S, Xu A, Bendahl PO, et al
    Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch.
    BJU Int. 2017;120:530-536.
    PubMed     Text format     Abstract available


    Cancer Biomark

  9. XIONG J, Xiong K, Bing Z
    Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Cancer Biomark. 2017 Nov 25. pii: CBM170314. doi: 10.3233/CBM-170314.
    PubMed     Text format     Abstract available

  10. LIAO X, Chen J, Liu Y, He A, et al
    Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
    Cancer Biomark. 2017 Nov 27. pii: CBM170354. doi: 10.3233/CBM-170354.
    PubMed     Text format     Abstract available


    Cancer Gene Ther

  11. CAO X, Xu J, Yue D
    LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer.
    Cancer Gene Ther. 2017 Dec 12. pii: 10.1038/s41417-017-0006.
    PubMed     Text format     Abstract available


    Cancer Invest

  12. LIEBERMAN-CRIBBIN W, Galsky M, Casey M, Liu B, et al
    Hospital Centralization Impacts High-Risk Lung and Bladder Cancer Surgical Patients.
    Cancer Invest. 2017;35:652-661.
    PubMed     Text format     Abstract available


    Cancer Sci

  13. SUEKANE S, Ueda K, Nishihara K, Sasada T, et al
    Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.
    Cancer Sci. 2017;108:2430-2437.
    PubMed     Text format     Abstract available


    Cell Death Dis

  14. RAMAKRISHNAN S, Hu Q, Krishnan N, Wang D, et al
    Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.
    Cell Death Dis. 2017;8:3217.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  15. CHEN CH, Changou C, Hsieh TH, Lee YC, et al
    Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer.
    Clin Cancer Res. 2017 Dec 8. pii: 1078-0432.CCR-17-2066.
    PubMed     Text format     Abstract available


    Clin Rehabil

  16. RAMMANT E, Decaestecker K, Bultijnck R, Sundahl N, et al
    A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy.
    Clin Rehabil. 2017 Dec 1:269215517746472. doi: 10.1177/0269215517746472.
    PubMed     Text format     Abstract available


    Eur Urol

  17. OOSTERLINCK W, Decaestecker K
    Re: Active Surveillance for Low-risk Nonmuscle Invasive Bladder Cancer (NMIBC): a Confirmatory and Resource Consumption Study from Bladder Cancer Italian Active Surveillance (BIAS) Project.
    Eur Urol. 2017 Dec 7. pii: S0302-2838(17)31018.
    PubMed     Text format    

  18. CUMBERBATCH MG, Catto JWF
    Re: Comprehensive Molecular Characterization of Muscle Invasive Bladder Cancer.
    Eur Urol. 2017 Dec 5. pii: S0302-2838(17)31007.
    PubMed     Text format    


    Expert Opin Emerg Drugs

  19. JAMY O, Sonpavde G
    Emerging first line treatment options for bladder cancer: A review of phase II and III therapies in the pipeline.
    Expert Opin Emerg Drugs. 2017 Dec 10. doi: 10.1080/14728214.2017.1416092.
    PubMed     Text format     Abstract available


    Expert Rev Clin Pharmacol

  20. CRIST M, Balar A
    Atezolizumab in invasive and metastatic urothelial carcinoma.
    Expert Rev Clin Pharmacol. 2017;10:1295-1301.
    PubMed     Text format     Abstract available


    Front Physiol

  21. LI S, Liu X, Liu T, Meng X, et al
    Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.
    Front Physiol. 2017;8:947.
    PubMed     Text format     Abstract available


    Int Braz J Urol

  22. ZATTONI F, Morlacco A, Nehra A, Frank I, et al
    Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse.
    Int Braz J Urol. 2017;43.
    PubMed     Text format     Abstract available


    Int J Cancer

  23. INOUE-CHOI M, Hartge P, Liao LM, Caporaso N, et al
    Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort.
    Int J Cancer. 2018;142:271-280.
    PubMed     Text format     Abstract available

  24. SHI X, Zhang X, Li J, Mo L, et al
    PD-1 blockade enhances the anti-tumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Int J Cancer. 2017 Dec 15. doi: 10.1002/ijc.31219.
    PubMed     Text format     Abstract available

  25. WESTHOFF E, Wu X, Kiemeney LA, Lerner SP, et al
    Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer.
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31214.
    PubMed     Text format     Abstract available


    J Cancer Res Ther

  26. LIU H, Chang J, Zhao Z, Li Y, et al
    Effects of exogenous hydrogen sulfide on the proliferation and invasion of human Bladder cancer cells.
    J Cancer Res Ther. 2017;13:829-832.
    PubMed     Text format     Abstract available


    J Cell Biochem

  27. ZHU F, Zhang X, Yu Q, Han G, et al
    LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression.
    J Cell Biochem. 2017 Dec 12. doi: 10.1002/jcb.26556.
    PubMed     Text format     Abstract available


    J Clin Oncol

  28. BOOTH CM, Karim S, Peng Y, Siemens DR, et al
    Radical Treatment of the Primary Tumor in Metastatic Bladder Cancer: Potentially Dangerous Findings From Observational Data.
    J Clin Oncol. 2017 Dec 13:JCO2017761759. doi: 10.1200/JCO.2017.76.1759.
    PubMed     Text format    


    J Exp Clin Cancer Res

  29. ISONO M, Hoffmann MJ, Pinkerneil M, Sato A, et al
    Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.
    J Exp Clin Cancer Res. 2017;36:1.
    PubMed     Text format     Abstract available


    J Geriatr Oncol

  30. BONET M, Bonfill T, Nunez M, Mur E, et al
    Trimodality therapy for older patients with bladder cancer: Overtreatment or benefit?
    J Geriatr Oncol. 2017 Dec 7. pii: S1879-4068(17)30244.
    PubMed     Text format    


    J Magn Reson Imaging

  31. WANG F, Jin D, Hua XL, Zhao ZZ, et al
    Investigation of diffusion kurtosis imaging for discriminating tumors from inflammatory lesions after treatment for bladder cancer.
    J Magn Reson Imaging. 2017 Dec 12. doi: 10.1002/jmri.25924.
    PubMed     Text format     Abstract available


    Klin Onkol

  32. BUCHLER T
    [Immunotherapy for Bladder Cancer].
    Klin Onkol. 2017;30.
    PubMed     Text format     Abstract available


    Minerva Urol Nefrol

  33. CICIONE A, Manno S, Ucciero G, Cantiello F, et al
    A larger detrusor wall thickness increases the risk of non muscle invasive bladder cancer recurrence and progression: result from a multicenter observational study.
    Minerva Urol Nefrol. 2017 Dec 14. pii: S0393-2249.17.02992.
    PubMed     Text format     Abstract available


    Oncotarget

  34. ZHANG Y, Jia L, Zhang Y, Ji W, et al
    Higher expression of FOXOs correlates to better prognosis of bladder cancer.
    Oncotarget. 2017;8:96313-96322.
    PubMed     Text format     Abstract available

  35. VANTAKU V, Donepudi SR, Ambati CR, Jin F, et al
    Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer.
    Oncotarget. 2017;8:95620-95631.
    PubMed     Text format     Abstract available

  36. SEO HK, Kim SH, Ahn KO, Lee SJ, et al
    Recommended oral sodium bicarbonate administration for urine alkalinization did not affect the concentration of mitomycin-C in non-muscle invasive bladder cancer patients.
    Oncotarget. 2017;8:96117-96125.
    PubMed     Text format     Abstract available


    PLoS One

  37. TAE BS, Jeong CW, Kwak C, Kim HH, et al
    Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
    PLoS One. 2017;12:e0189354.
    PubMed     Text format     Abstract available

  38. LINDQUIST KJ, Sanford T, Friedlander TW, Paris PL, et al
    Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumors.
    PLoS One. 2017;12:e0187975.
    PubMed     Text format     Abstract available


    Psychooncology

  39. ANDERSON CB, Rapkin B, Reaves BC, Sun AJ, et al
    Idiographic quality of life assessment before radical cystectomy.
    Psychooncology. 2017;26:206-213.
    PubMed     Text format     Abstract available


    Therapie

  40. LE BORGNE P, Brunhuber C, Baicry F, Zumstein C, et al
    [BCGitis: An unusual complication after intravesical immunotherapy].
    Therapie. 2017;72:509-511.
    PubMed     Text format    


    Urol Clin North Am

  41. PEARCE SM, Daneshmand S
    Continent Cutaneous Diversion.
    Urol Clin North Am. 2018;45:55-65.
    PubMed     Text format     Abstract available

  42. PIETZAK EJ, Donahue TF, Bochner BH
    Male Neobladder.
    Urol Clin North Am. 2018;45:37-48.
    PubMed     Text format     Abstract available

  43. THRESS TM, Cookson MS, Patel S
    Robotic Cystectomy with Intracorporeal Urinary Diversion: Review of Current Techniques and Outcomes.
    Urol Clin North Am. 2018;45:67-77.
    PubMed     Text format     Abstract available


    Urol Nurs

  44. GEZGINCI E, Yyigun E, Yalcin S, Ozgok IY, et al
    Symptoms Control for Patients with Superficial Bladder Cancers Before and After TURBT and Intravesical Epirubicin Instillation.
    Urol Nurs. 2017;37:31-5.
    PubMed     Text format     Abstract available


    Urol Oncol

  45. XYLINAS E, Kent M, Dabi Y, Rieken M, et al
    Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C.
    Urol Oncol. 2017 Dec 5. pii: S1078-1439(17)30595.
    PubMed     Text format     Abstract available


    Urologiia

  46. PERLIN DV, Aleksandrov IV, Zipunnikov VP, Popova M, et al
    [Laparoscopic radical cystectomy: innovations and classics].
    Urologiia. 2017;:26-30.
    PubMed     Text format     Abstract available


    Virchows Arch

  47. RODRIGUEZ PENA MDC, Tregnago AC, Eich ML, Springer S, et al
    Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder.
    Virchows Arch. 2017;471:761-767.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: